Literature DB >> 7882807

Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Follow-up of the Berlin Retinopathy Study.

T Danne1, B Weber, R Hartmann, I Enders, W Burger, G Hovener.   

Abstract

OBJECTIVE: To assess the influence of long-term glycemic control on the development of background retinopathy in adolescents followed longitudinally from the onset of insulin-dependent diabetes mellitus (IDDM). RESEARCH DESIGN AND METHODS: Repeated retinal fluorescein angiographies, in intervals of 1-2 years, were evaluated prospectively in 346 patients (190 males, 156 females; 19.8 [8.8-35.4] years of age; diabetes duration of 10.4 [1.1-27.4] years at their latest eye examination, median [range]). The influences of long-term HbA1c (mean of 18 [1-95] determinations per person) and microalbuminuria (> or = 2 of > or = 3 measurements > or = 15 micrograms/min x 1.73 m2) were studied by multiple linear regression, life-table analysis, and trend analyses.
RESULTS: The rate of background retinopathy per 100 patient-years increased with poorer glycemic control from 0.7 (long-term HbA1c < 7% to 7.3 (HbA1c > 11%) following an exponential function. Life-table analysis after subdivision in HbA1c quartiles of equal sizes (HbA1c < 8, 8-9, 9-10, and > 10%) revealed an individual median expectation of background retinopathy after more than 25, 16.2, 12.7, or 12.0 years of diabetes, respectively. However, significant differences were found only between 8-9% and 9-10%, calculated either as prevalence, life-table analysis, or relative incidence, thus suggesting that a threshold model may also fit the data. After 12 years of diabetes, < 25% of those patients exhibiting microalbuminuria (n = 18) were expected to be free from retinopathy compared with 81% of those with normoalbuminuria (n = 86).
CONCLUSIONS: Two statistical models are appropriate to explain the relationship between glycemic control and risk for background retinopathy: 1) a continuous exponential relationship as described by the DCCT or 2) the presence of a threshold HbA1c level at 9%. Thus, diabetes treatment in children should aim at long-term HbA1c levels < 9.0%, but every progress closer to normal may further reduce the risk.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7882807     DOI: 10.2337/diacare.17.12.1390

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  11 in total

1.  Markers of microvascular complications in insulin dependent diabetes.

Authors:  C J Schultz; R Amin; D B Dunger
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

Review 2.  New developments in the treatment of type 1 diabetes in children.

Authors:  Thomas Danne; Karin Lange; Olga Kordonouri
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

3.  Natural history of retinopathy in children and young people with type 1 diabetes.

Authors:  N Dhillon; A Karthikeyan; A Castle; P Dodson; W Högler; J Kirk; N Krone; J Nolan; T Barrett
Journal:  Eye (Lond)       Date:  2016-04-22       Impact factor: 3.775

Review 4.  100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention.

Authors:  Anette-Gabriele Ziegler; Thomas Danne; Carolin Daniel; Ezio Bonifacio
Journal:  Med (N Y)       Date:  2021-09-15

Review 5.  Complications of pediatric and adolescent type 1 diabetes mellitus.

Authors:  S J Brink
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

6.  Puberty and type 1 diabetes.

Authors:  Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2015-04

Review 7.  Epidemiological issues in diabetic retinopathy.

Authors:  Peter H Scanlon; Stephen J Aldington; Irene M Stratton
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

8.  Risk factors associated with retinopathy in young people with type 1 diabetes in Bangladesh.

Authors:  Bedowra Zabeen; Mohammad Zafar Khaled; Lutful Husain; Asma Aktar; Kamrul Huda; Yeasmin Afroz Kamal; Nujhat Choudhury; Kishwar Azad
Journal:  Endocrinol Diabetes Metab       Date:  2020-12-17

9.  Chromatographic fractions from Chrysophyllum albidum stem bark boost antioxidant enzyme activity and ameliorate some markers of diabetes complications.

Authors:  Babalola Ola Yusuf; Musa Toyin Yakubu; Musbau Adewumi Akanji
Journal:  J Tradit Complement Med       Date:  2021-01-21

10.  BRIGHT Guidelines on Self-Monitoring of Blood Glucose.

Authors:  Abdul Basit; Asima Khan; Riasat Ali Khan
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.